Autosomal dominant nonsyndromic hearing loss: genes and variants

Explore variant evidence for Autosomal dominant nonsyndromic hearing loss across 12 analyzed proteins (KCNQ4, TECTA, MYO7A, SIX1, GJB2 and 7 more). Linked ClinVar records include 72 pathogenic or likely pathogenic variants, 312 variants of uncertain significance and 93 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Autosomal dominant nonsyndromic hearing loss

Weakly linked (only a few uncertain records): ABCC1 and USH2A.

Where Autosomal dominant nonsyndromic hearing loss variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant nonsyndromic hearing loss

VariantPositionProtein partClinical label
MYO7A E450V450Myosin motorPathogenic / likely pathogenic (★★)
GJB2 T86R86TransmembranePathogenic / likely pathogenic (★★)
KCNQ4 L281S281Segment H5Pathogenic / likely pathogenic (★★)
MYO7A G1497R1497FERM 1Pathogenic / likely pathogenic (★★)
TECTA R2021H2021ZPPathogenic / likely pathogenic (★★)
GJB2 R32L32TransmembranePathogenic / likely pathogenic (★★)
GJB2 I82M82TransmembranePathogenic / likely pathogenic (★★)
GJB2 E147K147TransmembranePathogenic / likely pathogenic (★★)
GJB2 R184W184ExtracellularPathogenic / likely pathogenic (★★)
MYO7A E450Q450Myosin motorPathogenic / likely pathogenic (★★)
TECTA R2021C2021ZPPathogenic / likely pathogenic (★★)
KCNQ4 P291L291Segment H5Pathogenic / likely pathogenic (★★)
MYO7A R241G241Myosin motorPathogenic / likely pathogenic (★★)
MYO7A A397T397Myosin motorPathogenic / likely pathogenic (★★)
MYO7A R657W657Myosin motorPathogenic / likely pathogenic (★★)
MYO7A R668H668Myosin motorPathogenic / likely pathogenic (★★)
MYO7A R853C853IQ 5Pathogenic / likely pathogenic (★★)
MYO7A G2137R2137FERM 2Pathogenic / likely pathogenic (★★)
SIX1 R110W110Pathogenic / likely pathogenic (★★)
MYO7A M1I1Pathogenic / likely pathogenic (★★)
GJB6 A88V88TransmembranePathogenic / likely pathogenic (★★)
MYO7A D2010N2010FERM 2Pathogenic / likely pathogenic (★★)
MYO7A G2163S2163FERM 2Pathogenic / likely pathogenic (★★)
SIX1 E125K125HomeoboxPathogenic / likely pathogenic (★★)
TECTA C1057S1057Pathogenic / likely pathogenic (★★)
TMC1 I677T677ExtracellularPathogenic / likely pathogenic (★★)
KCNQ4 L47P47CytoplasmicPathogenic / likely pathogenic (★★)
TMC1 I266T266ExtracellularPathogenic / likely pathogenic (★★)
TMC1 D684H684ExtracellularPathogenic / likely pathogenic (★★)
GJB2 D179H179ExtracellularPathogenic / likely pathogenic (★)
TECTA C1837Y1837ZPPathogenic / likely pathogenic (★)
GJB2 D179N179ExtracellularPathogenic / likely pathogenic (★)
KCNQ4 G287S287Segment H5Pathogenic / likely pathogenic (★)
TECTA C1837R1837ZPPathogenic / likely pathogenic (★)
KCNQ4 W224R224CytoplasmicPathogenic / likely pathogenic (★)
KCNQ4 G321S321Segment S6Pathogenic / likely pathogenic (★)
KCNQ4 W276R276Segment H5Pathogenic / likely pathogenic (★)
SIX1 Y129C129HomeoboxPathogenic / likely pathogenic (★)
GJB6 G11R11CytoplasmicPathogenic / likely pathogenic (★)
KCNQ4 H234L234CytoplasmicPathogenic / likely pathogenic (★)
KCNQ4 F549L549Interaction with CALMPathogenic / likely pathogenic (★)
SIX1 R110L110Pathogenic / likely pathogenic (★)
GJB2 P58S58ExtracellularPathogenic / likely pathogenic (★)
KCNQ4 G245R245Segment S5Pathogenic / likely pathogenic (★)
MYO7A D511N511Myosin motorPathogenic / likely pathogenic (★)
POLE R37P37Pathogenic / likely pathogenic (★)
TECTA T190P190NIDOPathogenic / likely pathogenic (★)
TECTA G434V434VWFD 1Pathogenic / likely pathogenic (★)
TECTA S1847P1847ZPPathogenic / likely pathogenic (★)
TECTA Y1870C1870ZPPathogenic / likely pathogenic (★)
TECTA R1890C1890ZPPathogenic / likely pathogenic (★)
SIX1 V106L106Pathogenic / likely pathogenic (★)
SIX1 K114E114Pathogenic / likely pathogenic (★)
SIX1 P118L118Pathogenic / likely pathogenic (★)
KCNQ4 D266Y266ExtracellularPathogenic / likely pathogenic (★)
KCNQ4 P291S291Segment H5Pathogenic / likely pathogenic
KCNQ4 G287R287Segment H5Pathogenic / likely pathogenic
TECTA C1837G1837ZPPathogenic / likely pathogenic
KCNQ4 V230E230CytoplasmicPathogenic / likely pathogenic
KCNQ4 L274H274Segment H5Pathogenic / likely pathogenic

Showing 60 of 72.

Which prediction tools work for Autosomal dominant nonsyndromic hearing loss

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Autosomal dominant nonsyndromic hearing loss

Frequently asked questions

Which genes have records linked to Autosomal dominant nonsyndromic hearing loss?

This view contains 12 analyzed proteins: KCNQ4, TECTA, MYO7A, SIX1, GJB2 and 7 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 72 pathogenic or likely pathogenic variants, 312 variants of uncertain significance and 93 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 606 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center